|
PLRG1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.23849999980708E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.36679999996181E-07 |
| Normal-vs-Stage2 |
4.603800E-03 |
| Normal-vs-Stage3 |
2.952100E-04 |
| Normal-vs-Stage4 |
1.054060E-02 |
| Stage1-vs-Stage2 |
3.904800E-01 |
| Stage1-vs-Stage3 |
8.738200E-01 |
| Stage1-vs-Stage4 |
8.161400E-01 |
| Stage2-vs-Stage3 |
4.604400E-01 |
| Stage2-vs-Stage4 |
6.819800E-01 |
| Stage3-vs-Stage4 |
8.913200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.54349999950776E-07 |
| Normal-vs-AfricanAmerican |
2.031700E-04 |
| Normal-vs-Asian |
1.813580E-01 |
| Caucasian-vs-AfricanAmerican |
4.580000E-01 |
| Caucasian-vs-Asian |
9.324400E-01 |
| AfricanAmerican-vs-Asian |
8.557200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.89959999952194E-08 |
| Normal-vs-Female |
3.840900E-03 |
| Male-vs-Female |
3.184100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.362440E-04 |
| Normal-vs-Extreme_Weight |
2.20989999966115E-07 |
| Normal-vs-Obese |
7.65799999999928E-05 |
| Normal-vs-Extreme_Obese |
8.243800E-04 |
| Normal_Weight-vs-Extreme_Weight |
6.051200E-01 |
| Normal_Weight-vs-Obese |
6.128200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.904400E-01 |
| Extreme_Weight-vs-Obese |
2.298600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.971200E-01 |
| Obese-vs-Extreme_Obese |
4.398400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.633000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.80410000000442E-05 |
| Normal-vs-Age(61-80Yrs) |
1.54499999460711E-08 |
| Normal-vs-Age(81-100Yrs) |
7.86010000000115E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.216800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.075780E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.048030E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.075600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.655560E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.184400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.72519999996901E-06 |
| Normal-VS-Type2 PRCC |
3.62409999998814E-06 |
| Normal-VS-KIRP CIMP |
1.218160E-01 |
| Normal-VS-Unclassified PRCC |
2.191500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
6.674000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.042000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.072400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.726200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.240390E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.908000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.70750000028086E-07 |
| Normal-vs-N1 |
4.122300E-02 |
| Normal-vs-N2 |
1.830170E-04 |
| N0-vs-N1 |
1.591710E-02 |
| N0-vs-N2 |
5.319200E-03 |
| N1-vs-N2 |
7.78439999999936E-05 |
|
|
